Cite
HARVARD Citation
Klesse, L. et al. (2020). The Use of MEK Inhibitors in Neurofibromatosis Type 1–Associated Tumors and Management of Toxicities. Oncologist. pp. e1109-e1116. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Klesse, L. et al. (2020). The Use of MEK Inhibitors in Neurofibromatosis Type 1–Associated Tumors and Management of Toxicities. Oncologist. pp. e1109-e1116. [Online].